AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study

Macular Diseases

Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric study

Br J Ophthalmol

Ruiz-Medrano J, Udaondo Mirete P, Fernández-Jiménez M, Asencio-Duran M, Fernández-Vigo JI, Medina-Baena M, Flores-Moreno I, Pareja-Esteban J, Touhami S, Giocanti-Aurégan A, Cicinelli MV, Loewenstein A, Ruiz-Moreno JM

doi: 10.1136/bjo-2024-325665

Macular Diseases

Long-Term Efficacy and Safety of CT-P42 in Patients with Diabetic Macular Edema: 52-Week Results from a Phase 3 Randomized Clinical Trial

Ophthalmol Ther

Brown DM, Wolf S, Veselovsky M, Veith M, Papp A, Mange S, Mondal LK, Romanczak D, Janco L, Chauhan R, Romanowska-Dixon B, Eremina A, Dusova J, Sagong M, Kim S, Bae Y, Kim S, Bae Y, Son D, Kang H, Choi S, Stanga PE

doi: 10.1007/s40123-025-01197-w

Macular DiseasesRetinal Diseases

Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial

JAMA Ophthalmol

Pieramici DJ, Awh CC, Chang M, Emanuelli A, Holekamp NM, Hu AY, Suñer IJ, Wykoff CC, Brittain C, Howard D, Quezada-Ruiz C, Santhanakrishnan A, Latkany P

doi: 10.1001/jamaophthalmol.2025.0001

Macular Diseases

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial

JAMA Ophthalmol

Khanani AM, Campochiaro PA, Graff JM, Marcus DM, Miller D, Mittra RA, Regillo C, Sheth VS, Bobbala A, Gune S, Lin S, Quezada-Ruiz C, Malhotra V

doi: 10.1001/jamaophthalmol.2025.0006

Macular Diseases

Influence of Common Medications on Diabetic Macular Edema in Type 2 Diabetes Mellitus

Ophthalmol Retina

Muayad J, Loya A, Hussain ZS, Lee DH, Chauhan MZ, Lee AG, Movahedan A, Dahr SS

doi: 10.1016/j.oret.2024.12.006

Macular Diseases

Anatomic biomarkers as potential endpoints in diabetic macular edema: Systematic literature review with identification of macular volume as a key surrogate for visual acuity

Surv Ophthalmol

Couturier A, Wykoff CC, Lupidi M, Udaondo P, Peto T, Pintard PJ

doi: 10.1016/j.survophthal.2025.04.004

Cornea and Corneal DiseasesFurther Publications

Endothelial Cell Loss 1 Year After Successful DMEK in the Diabetes Endothelial Keratoplasty Study: A Randomized Clinical Trial

JAMA Ophthalmol

Lass JH, Benetz BA, Verdier DD, Szczotka-Flynn LB, Bauza CE, Reed ZW, Greiner MA, Mian SI, Patel SV, Pramanik S, Price FW Jr, Soper MC, Terry MA, Titus MS, Kollman C, Beck RW, Price MO, Diabetes Endothelial Keratoplasty Study Group

doi: 10.1001/jamaophthalmol.2025.4261

Macular Diseases

Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents

J Clin Med

Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S, Terasaki H, Kondo M, Writing Committee Of Japan-Clinical Retina Study Group J-Crest

doi: 10.3390/jcm13237336

Macular Diseases

Race and Vision Outcomes in Ranibizumab-Treated Participants With Diabetic Macular Edema: A Meta-Analysis

JAMA Ophthalmol

Khan MA, Hill L, Stoilov I, Haller JA

doi: 10.1001/jamaophthalmol.2024.6371

Related content

Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric study

Long-Term Efficacy and Safety of CT-P42 in Patients with Diabetic Macular Edema: 52-Week Results from a Phase 3 Randomized Clinical Trial

Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial

Influence of Common Medications on Diabetic Macular Edema in Type 2 Diabetes Mellitus

Anatomic biomarkers as potential endpoints in diabetic macular edema: Systematic literature review with identification of macular volume as a key surrogate for visual acuity

Endothelial Cell Loss 1 Year After Successful DMEK in the Diabetes Endothelial Keratoplasty Study: A Randomized Clinical Trial

Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents

Race and Vision Outcomes in Ranibizumab-Treated Participants With Diabetic Macular Edema: A Meta-Analysis